M. Eric Gershwin

12.2k total citations · 1 hit paper
142 papers, 8.3k citations indexed

About

M. Eric Gershwin is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, M. Eric Gershwin has authored 142 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Hepatology, 49 papers in Epidemiology and 37 papers in Rheumatology. Recurrent topics in M. Eric Gershwin's work include Liver Diseases and Immunity (54 papers), Liver Disease Diagnosis and Treatment (41 papers) and Systemic Lupus Erythematosus Research (29 papers). M. Eric Gershwin is often cited by papers focused on Liver Diseases and Immunity (54 papers), Liver Disease Diagnosis and Treatment (41 papers) and Systemic Lupus Erythematosus Research (29 papers). M. Eric Gershwin collaborates with scholars based in United States, Italy and China. M. Eric Gershwin's co-authors include Carlo Selmi, Pietro Invernizzi, Andrea T. Borchers, Mauro Podda, Carl L. Keen, Ana Lleò, Robert M. Hackman, Judith S. Stern, Ross L. Coppel and Patrick S.C. Leung and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

M. Eric Gershwin

140 papers receiving 8.0k citations

Hit Papers

Molecular mimicry and autoimmunity 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Eric Gershwin United States 50 2.6k 2.4k 1.9k 1.5k 1.5k 142 8.3k
Dimitrios P. Bogdanos Greece 55 3.6k 1.4× 4.0k 1.6× 2.1k 1.1× 2.2k 1.4× 1.4k 0.9× 366 10.1k
M. Eric Gershwin United States 51 2.5k 1.0× 2.3k 0.9× 1.4k 0.7× 1.0k 0.7× 999 0.7× 149 6.9k
Patrick S.C. Leung United States 62 5.9k 2.3× 4.7k 2.0× 2.5k 1.3× 1.3k 0.9× 1.5k 1.0× 250 11.7k
Carlo Selmi Italy 68 4.8k 1.9× 5.0k 2.0× 3.3k 1.7× 3.4k 2.3× 2.3k 1.5× 386 15.0k
Albert Tran France 48 3.1k 1.2× 4.8k 2.0× 1.1k 0.6× 391 0.3× 1.5k 1.0× 200 8.5k
Hirohito Tsubouchi Japan 55 5.7k 2.2× 4.4k 1.8× 1.2k 0.6× 630 0.4× 2.1k 1.4× 319 10.5k
Detlef Schuppan Germany 66 3.6k 1.4× 6.3k 2.6× 1.2k 0.6× 385 0.3× 3.0k 2.0× 231 13.6k
Giuseppe Montalto Italy 56 1.4k 0.6× 2.5k 1.0× 869 0.5× 299 0.2× 3.7k 2.5× 346 11.7k
Tilo Andus Germany 45 700 0.3× 2.5k 1.0× 3.3k 1.7× 507 0.3× 2.3k 1.5× 119 10.4k
Marshall M. Kaplan United States 49 6.0k 2.4× 5.8k 2.4× 786 0.4× 1.1k 0.7× 1.1k 0.7× 143 10.9k

Countries citing papers authored by M. Eric Gershwin

Since Specialization
Citations

This map shows the geographic impact of M. Eric Gershwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Eric Gershwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Eric Gershwin more than expected).

Fields of papers citing papers by M. Eric Gershwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Eric Gershwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Eric Gershwin. The network helps show where M. Eric Gershwin may publish in the future.

Co-authorship network of co-authors of M. Eric Gershwin

This figure shows the co-authorship network connecting the top 25 collaborators of M. Eric Gershwin. A scholar is included among the top collaborators of M. Eric Gershwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Eric Gershwin. M. Eric Gershwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Bingyi, et al.. (2024). The importance of developing reproducible primary endpoints for clinical trials in systemic lupus erythematosus. Clinical Rheumatology. 44(1). 183–192. 1 indexed citations
2.
Bhat, R. G., et al.. (2023). Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity. Clinical Reviews in Allergy & Immunology. 65(1). 86–100. 14 indexed citations
3.
Rojas, Manuel, Paula Restrepo-Jiménez, Diana M. Monsalve, et al.. (2018). Molecular mimicry and autoimmunity. Journal of Autoimmunity. 95. 100–123. 380 indexed citations breakdown →
4.
Hudspeth, Kelly, Matteo Donadon, Matteo Cimino, et al.. (2015). Human liver-resident CD56bright/CD16neg NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. Journal of Autoimmunity. 66. 40–50. 195 indexed citations
5.
Borchers, Andrea T. & M. Eric Gershwin. (2013). Complex regional pain syndrome: A comprehensive and critical review. Autoimmunity Reviews. 13(3). 242–265. 133 indexed citations
6.
Lleò, Ana, M. Eric Gershwin, Alberto Mantovani, & Pietro Invernizzi. (2011). Towards common denominators in primary biliary cirrhosis: The role of IL-12. Journal of Hepatology. 56(3). 731–733. 33 indexed citations
7.
Selmi, Carlo, et al.. (2009). Currents Concepts on the Immunopathology of Amyloidosis. Clinical Reviews in Allergy & Immunology. 38(2-3). 97–106. 47 indexed citations
8.
Matthias, Torsten, et al.. (2009). Diagnostic Challenges in Celiac Disease and the Role of the Tissue Transglutaminase–Neo-Epitope. Clinical Reviews in Allergy & Immunology. 38(2-3). 298–301. 25 indexed citations
9.
Zhong, Bihui, Pavel Strnad, Carlo Selmi, et al.. (2009). Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity†. Hepatology. 50(2). 546–554. 39 indexed citations
10.
Lleò, Ana, Carlo Selmi, Pietro Invernizzi, et al.. (2009). Apotopes and the biliary specificity of primary biliary cirrhosis†. Hepatology. 49(3). 871–879. 159 indexed citations
11.
Selmi, Carlo & M. Eric Gershwin. (2009). The role of environmental factors in primary biliary cirrhosis. Trends in Immunology. 30(8). 415–420. 60 indexed citations
12.
Lleò, Ana, Pier Maria Battezzati, Carlo Selmi, M. Eric Gershwin, & Mauro Podda. (2008). Is autoimmunity a matter of sex?. Autoimmunity Reviews. 7(8). 626–630. 147 indexed citations
13.
Selmi, Carlo, Massimo Zuin, & M. Eric Gershwin. (2008). The unfinished business of primary biliary cirrhosis. Journal of Hepatology. 49(3). 451–460. 33 indexed citations
14.
Selmi, Carlo, M. Eric Gershwin, Keith D. Lindor, et al.. (2007). Quality of life and everyday activities in patients with primary biliary cirrhosis. Hepatology. 46(6). 1836–1843. 33 indexed citations
15.
Selmi, Carlo, Lauren Grace Mackey, & M. Eric Gershwin. (2007). The Immunological Milieu of the Liver. Seminars in Liver Disease. 27(2). 129–139. 65 indexed citations
16.
Invernizzi, Pietro, Monica Miozzo, Carlo Selmi, et al.. (2005). X Chromosome Monosomy: A Common Mechanism for Autoimmune Diseases. The Journal of Immunology. 175(1). 575–578. 144 indexed citations
17.
Ólafsson, Sigurður, H Gudjónsson, Carlo Selmi, et al.. (2004). Antimitochondrial Antibodies and Reactivity to N. Aromaticivorans Proteins in Icelandic Patients with Primary Biliary Cirrhosis and Their Relatives. The American Journal of Gastroenterology. 99(11). 2143–2146. 40 indexed citations
18.
Harkey, Martha R., Gary L. Henderson, M. Eric Gershwin, Judith S. Stern, & Robert M. Hackman. (2001). Variability in commercial ginseng products: an analysis of 25 preparations. American Journal of Clinical Nutrition. 73(6). 1101–1106. 236 indexed citations
19.
20.
Naiki, Mitsuru, et al.. (1994). Activation of Autoreactive T-cell clones from NZB.H-2bm12 mice. Journal of Autoimmunity. 7(3). 275–290. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026